Search

everythinglearnresearchcommunity

for

Search:↓

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

EBV infection increases a specific keratin variant in carcinoma cells, possibly affecting cell structure and cancer progression.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

A rare nail bed cancer was successfully treated with no recurrence after 4 years.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

Eclipta alba extract shows potential as an anticancer agent by inhibiting cancer cell growth and promoting cell death.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

FDG PET/CT scans can change cancer treatment plans for dogs.

Scalp cooling can help prevent hair loss from chemotherapy without raising cancer spread risk.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

New compounds may help treat prostate cancer by reducing cell growth.

FDG PET/CT can improve cancer treatment plans in dogs.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

Deleting TNFα gene reduces skin cancer risk in certain mice.

A 69-year-old smoker was wrongly diagnosed with lung cancer but actually had a rare lymphatic system disorder.

A cat's hair loss was linked to a severe pancreatic cancer.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.